Evidence map›Paper›PMID 29184623›Full record

ArticleJournal of extracellular vesicles2017

Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane.

Kerstin Menck, Can Sönmezer, Thomas Stefan Worst, Matthias Schulz, Gry Helene Dihazi, Frank Streit, Gerrit Erdmann, Simon Kling, Michael Boutros, Claudia Binder and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 225 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
225citing papers in PubMed, 4 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

225 citing papers in PubMed, 4 syntheses or guidelines pooled it, 342 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Sirtuin 1 Is Required for Optimal Mammarenavirus Multiplication.bioRxiv : the preprint server for biology · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

165 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Kerstin MenckINSERM, U1068, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, and Université Aix-Marseille, Marseille, France.ORCID 0000-0002-8188-0163
Can SönmezerHematology and Oncology/Developmental Biochemistry, University Medical Center Goettingen, Goettingen, Germany.
Thomas Stefan WorstDepartment of Urology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
Matthias SchulzHematology and Oncology, University Medical Center Goettingen, Goettingen, Germany.
Gry Helene DihaziDepartment of Clinical Chemistry, University Medical Center Goettingen, Goettingen, Germany.
Frank StreitDepartment of Clinical Chemistry, University Medical Center Goettingen, Goettingen, Germany.
Gerrit ErdmannNMI TT Pharmaservices, Berlin, Germany.
Simon KlingNMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany.
Michael BoutrosDivision Signaling and Functional Genomics, German Cancer Research Center (DKFZ) and Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-9458-817X
Claudia BinderHematology and Oncology, University Medical Center Goettingen, Goettingen, Germany.
Julia Christina GrossHematology and Oncology/Developmental Biochemistry, University Medical Center Goettingen, Goettingen, Germany.ORCID 0000-0002-8939-5664
Nephrologisches Zentrum Goettingen · DEGerman Cancer Research Center · DECentre National de la Recherche Scientifique · FRFisher Bioservices (United States) · USNatural and Medical Sciences Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) are membrane particles secreted from cells into all body fluids. Several EV populations exist differing in size and cellular origin. Using differential centrifugation EVs pelleting at 14,000 g ("microvesicles" (MV)) and 100,000 g ("exosomes") are distinguishable by protein markers. Neutral sphingomyelinase (nSMase) inhibition has been shown to inhibit exosome release from cells and has since been used to study their functional implications. How nSMases (also known as SMPD2 and SMPD3) affect the basal secretion of MVs is unclear. Here we investigated how SMPD2/3 impact both EV populations. SMPD2/3 inhibition by GW4869 or RNAi decreases secretion of exosomes, but also increases secretion of MVs from the plasma membrane. Both populations differ significantly in metabolite composition and Wnt proteins are specifically loaded onto MVs under these conditions. Taken together, our data reveal a novel regulatory function of SMPD2/3 in vesicle budding from the plasma membrane and clearly suggest that - despite the different vesicle biogenesis - the routes of vesicular export are adaptable.

Indexed as

exosomesextracellular vesiclesGW4869microvesiclesneutral sphingomyelinaseSphingomyelinase

Identifiers

PMID29184623
PMCPMC5699186
OpenAlexW2758269250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.